Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia

NCT02662569 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

986

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes, Hyperlipidemia, Mixed Dyslipidemia

Interventions

BIOLOGICAL: Evolocumab
DRUG: Atorvastatin
OTHER: Placebo

Sponsor

Amgen